OMEPRAZOLE EXTENDED
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC under contract SPE2DP26F5901 for the procurement of OMEPRAZOLE EXTENDED, identified by NSN 6505016247068, under the parent delivery order SPE2DX25D9900. The award was issued on May 19, 2026, with the total contract price detailed in the official award documentation. This procurement is classified as a federal action under the Department of Defense and is managed through the DIBBS system, with the primary point of reference available via the official DIBBS link. The product is intended for federal use, though specific delivery locations and performance details are not provided in the available data. The solicitation was posted on July 21, 2026, and no set-aside classification or NAICS code was assigned for this transaction.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
